
    
      In this study all eligible patients were randomly allocated into two study groups by a
      permuted block randomization method: group A (control group) received only routine medical
      therapies and placebo injected into there knees.. Group B received mesenchymal stem cells in
      addition of routine medical therapy.

      Patients were categorized according to the following stimulation protocols:

      To assess the outcomes, after mesenchymal stem cells transplantation at months 1,3,6 and 12
      we will examine the patients by: WOMAC questioners, DAS28 scoring , radiographies assessments
      and biochemical analysis with laboratory tests.
    
  